Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN26944158Phase 2Completed
Phase 2, randomised, double-blind trial in asthma comparing Dexamethasone phosphate single-dose regimen with Prednisolone 3-day regimen (2 arms). Primary endpoint: Exacerbation severity. Started Jul 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN26944158.